89 search results
- Current search:
- Cancer
- Gynaecology
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
UpdatedCochrane EvidencePublished 29 Jun 2017
Drains versus no drains after pelvic lymphadenectomy to prevent lymphocyst formation in women with gynaecological cancer
Background This is an updated version of an original Cochrane review published in Issue 6, 2014. Pelvic lymphadenectomy (removal of lymph glands found in the pelvis) is an important component of the surgical management of gynaecological cancers to see if the cancer has spread. However, it can lead to complications, especially lymphocyst formation (collection ... -
Cochrane EvidencePublished 25 Mar 2017
Risk of endometrial cancer in subfertile women undergoing ovarian stimulation
Background For the treatment of subfertility (delay in becoming pregnant), several medications are used to stimulate ovulation - the process of maturation and release of eggs from the ovaries. These drugs may also affect the endometrium, which is the layer of tissue lining of the womb (uterus). However, conditions that cause subfertility are known ... -
Cochrane EvidencePublished 26 Jan 2017
Management of minor cytological abnormalities identified on cervical screening
The issue Cervical screening programmes reduce the risk of cervical cancer, through the use of cervical cytology (smear tests), which aim to detect and treat any precancerous changes which might put some women at risk of developing invasive disease (invasive cervical cancer) in the future. Usually only severe precancerous changes require treatment, ... -
Cochrane EvidencePublished 21 Jan 2017
Prophylactic antibiotics to prevent infection after cervical excision
Background Pre-cancerous cervical lesions can be treated by either excision or destruction of the abnormal cells from the cervix, to reduce the risk of developing cervical cancer in the future. The advantage of excisional treatment is that the abnormal cells are removed, rather than destroyed, so tissue can be sent for detailed examination to confirm ... -
Cochrane EvidencePublished 22 Nov 2016
Adjuvant (supplementary treatment after initial treatment) platinum-based anti-cancer drugs for early stage cervical cancer
Background Cervical cancer is the second most common cancer among women. Most women with early stage cervical cancer (stages I to IIA) are cured with surgery or, radiotherapy, or both. Radiotherapy uses high energy x-rays to damage tumour cells. Chemotherapy (anti-cancer) drugs use different ways to stop tumour cells dividing so they stop growing ... -
Cochrane EvidencePublished 13 Oct 2016
Laparoscopy versus laparotomy (open surgery) for early-stage ovarian cancer
Background Stage I ovarian cancer is diagnosed when the tumour is confined to one or both ovaries, without spread to lymph nodes or other parts of the body. Approximately 25% of women with ovarian cancer will be diagnosed at an early stage, thus the diagnosis often occurs due to an accidental finding. The intention of surgical staging is to establish ... -
Cochrane EvidencePublished 18 Jul 2016
Pain relief for women with pre-cancerous changes of the cervix (cervical intraepithelial neoplasia (CIN)) undergoing outpatient treatment
What is the issue? Treatment for CIN is usually undertaken in an outpatient colposcopy clinic to remove the pre-cancerous cells from the cervix (lower part of the womb). It commonly involves lifting the cells off the cervix with electrically heated wire (diathermy) or laser, or destroying the abnormal cells with freezing methods (cryotherapy). This ... -
Cochrane EvidencePublished 29 Jun 2016
The use of hormonal treatment in relapsed epithelial ovarian cancer
Background Epithelial ovarian cancer (EOC) arises from the cells covering the surface of the ovary. The majority of women with this type of cancer present with advanced stage disease at diagnosis. The initial treatment involves surgery (removal of as much disease as possible) followed by chemotherapy. In some cases chemotherapy is given to shrink ... -
Cochrane EvidencePublished 9 Jun 2016
First-line treatment with anti-cancer drugs for low-risk gestational trophoblastic neoplasia
What is the issue? Gestational trophoblastic neoplasia (GTN) is a rare but curable disease whereby a malignant tumour develops in the womb after a normal or molar pregnancy (where tissue develops in the womb instead of a baby). Women with GTN are classified as having low- or high-risk GTN using a specific scoring system. Virtually all women with low-risk ... -
Cochrane EvidencePublished 1 Mar 2016
Is a 'quick diagnosis' test on an ovarian mass during surgery accurate?
The issue When women go to their doctor with a mass that could be ovarian cancer, they are normally referred for surgery, since the mass may need to be removed and examined microscopically in a laboratory in a procedure known as paraffin section histopathology. A third of women with ovarian cancer present with a cyst or mass without any visible evidence ...
